Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

January 01, 1983; Volume 224,Issue 1
  • You have access
    Decreased beta adrenergic receptor density on human lymphocytes after chronic treatment with agonists.
    R D Aarons, A S Nies, J G Gerber and P B Molinoff
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 1-6;
  • You have access
    U-50,488: a selective and structurally novel non-Mu (kappa) opioid agonist.
    P F Vonvoigtlander, R A Lahti and J H Ludens
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 7-12;
  • You have access
    Withdrawal tolerance and unidirectional non-cross-tolerance in narcotic pellet-implanted mice.
    D G Lange, S C Roerig, J M Fujimoto and L W Busse
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 13-20;
  • You have access
    Effect of yohimbine on rat prolactin secretion.
    H Y Meltzer, M Simonovic and G A Gudelsky
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 21-27;
  • You have access
    Single-pass removal of [14C]-5-hydroxytryptamine and [3H]norepinephrine by rabbit lung, in vivo: kinetics and sites of removal.
    J D Catravas and C N Gillis
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 28-33;
  • You have access
    Tolerance to d-amphetamine and lack of cross-tolerance to other drugs in rats under a multiple schedule of food presentation.
    M J Brocco and D E McMillan
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 34-39;
  • You have access
    Pharmacological characterization of purinergic receptors in the rat vas deferens.
    D A Taylor, S Wiese, E P Faison and G G Yarbrough
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 40-45;
  • You have access
    Vascular effects of the stereoisomers of dobutamine.
    R R Ruffolo and E L Yaden
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 46-50;
  • You have access
    Inhibition of tail-flick and shaking responses by intrathecal and intraventricular D-Ala2-D-Leu5-enkephalin and beta-endorphin in anesthetized rats.
    L F Tseng, S S Cheng and J M Fujimoto
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 51-54;
  • You have access
    Interactions of phenobarbital with propranolol in the dog. 2. Bioavailability, metabolism and pharmacokinetics.
    V T Vu, S A Bai and F P Abramson
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 55-61;
  • You have access
    Interaction of phenobarbital with propranolol in the dog. 3. Beta blockade.
    S A Bai and F P Abramson
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 62-67;
  • You have access
    Effects of trifluoperazine on renin secretion of rat kidney slices.
    P C Churchill and M C Churchill
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 68-72;
  • You have access
    Role of protein binding in cocaine-induced hepatic necrosis.
    M A Evans
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 73-79;
  • You have access
    Differential-reinforcement-of-low-rate 72-second schedule: selective effects of antidepressant drugs.
    J M O'Donnell and L S Seiden
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 80-88;
  • You have access
    A kappa opioid effect: increased urination in the rat.
    J D Leander
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 89-94;
  • You have access
    Further characterization of the three-choice morphine, cyclazocine and saline discrimination paradigm: opioids with agonist and antagonist properties.
    J M White and S G Holtzman
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 95-99;
  • You have access
    Effects of nitroprusside and 8-bromo-cyclic GMP on the contractile activity of the rat aorta.
    T M Lincoln
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 100-107;
  • You have access
    45Ca fluxes in isolated toad bladder epithelial cells: effects of agents which alter water or sodium transport.
    R M Burch and P V Halushka
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 108-117;
  • You have access
    N-Ethylmaleimide-induced alteration in the interaction of agonists with muscarinic cholinergic receptors of rat brain.
    S J Korn, M W Martin and T K Harden
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 118-126;
  • You have access
    Behavioral effects of clozapine: comparison with thioridazine, chlorpromazine, haloperidol and chlordiazepoxide in squirrel monkeys.
    R D Spealman, R T Kelleher, S R Goldberg, J DeWeese and D M Goldberg
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 127-134;
  • You have access
    Botulinum neurotoxin type E: studies on mechanism of action and on structure-activity relationships.
    L L Simpson and B R Dasgupta
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 135-140;
  • You have access
    Factors influencing the efflux of hepatic glutathione into bile in rats.
    N Kaplowitz, D E Eberle, J Petrini, J Touloukian, M C Corvasce and J Kuhlenkamp
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 141-147;
  • You have access
    Pharmacological analysis of shaking behavior induced by enkephalins, thyrotropin-releasing hormone or serotonin in rats: evidence for different mechanisms.
    E G Drust and J D Connor
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 148-154;
  • You have access
    The effects of photoperiod on the responses of the hamster vas deferens to nerve stimulation.
    A Johns, R W Steger and A Bartke
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 155-160;
  • You have access
    RDS-127 (2-di-n-propylamino-4,7-dimethoxyindane): central effects of a new dopamine receptor agonist.
    S P Arnerić, J P Long, M Williams, D B Goodale, J Mott, J M Lakoski and G F Gebhart
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 161-170;
  • You have access
    A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.
    R L Cavanagh, J J Usakewicz and J P Buyniski
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 171-179;
  • You have access
    Disposition of caffeine and its metabolites in man.
    D D Tang-Liu, R L Williams and S Riegelman
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 180-185;
  • You have access
    Characterization of adrenergic receptor binding in rat lung: physiological regulation.
    J Latifpour and D B Bylund
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 186-192;
  • You have access
    Interactions of salsolinol and its mono-O-methylated analogs with adrenergic and dopaminergic receptors in the rabbit ear artery.
    S H Nelson and O S Steinsland
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 193-198;
  • You have access
    Relative potency of dopamine agonists on autoreceptor function in various brain regions of the rat.
    T C Westfall, L Naes and C Paul
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 199-205;
  • You have access
    Antihypertensive activity of LY141865, a selective presynaptic dopamine receptor agonist.
    R A Hahn, B R MacDonald and M A Martin
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 206-214;
  • You have access
    Use of selective antagonists for determining the types of receptors mediating the actions of 5-hydroxytryptamine and tryptamine in the isolated rabbit aorta.
    J S Stollak and R F Furchgott
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 215-221;
  • You have access
    Alpha and beta adrenoceptor blockade in normotensive and deoxycorticosterone (DOC)-hypertensive rats; plasma vasopressin and vasopressin pressor effect.
    M Burnier, J Biollaz, D B Brunner, H Gavras and H R Brunner
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 222-227;
  • You have access
    The effects of a beta-2 selective adrenergic receptor antagonist (ICI 118,551) on twitch tension in cat soleus muscle.
    H J Smith, S E Halliday and W Rouse
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 228-230;
  • You have access
    Postjunctional supersensitivity of the smooth muscle of the rat vas deferens induced by calmodulin-antagonizing drugs applied locally to the hypogastric plexus.
    K Goto
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 231-238;
  • You have access
    Inhibition of ouabain-induced increase in Na content of cultured myocardial cells by quinidine and procainamide.
    K Goshima and S Wakabayashi
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 239-246;
  • You have access
    Baroreflex sensitivity as a determinant of responses to hydralazine in dogs.
    H Vidrio
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 247-251;
  • You have access
    Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system.
    S R Slaughter, C N Statham, R M Philpot and M R Boyd
    Journal of Pharmacology and Experimental Therapeutics January 1983, 224 (1) 252-257;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 224, Issue 1
1 Jan 1983
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Smoking Could Worsen COVID-19 Outcome
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Potential Clinical Uses of CBG
  • Nose-to-Brain Delivery
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics